Compositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a
medical device or
coating. The formulations may also include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during
surgery of the
lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood,
interstitial fluid, or
cerebrospinal fluid. The formulation may be administered to a burn or ulcer. The formulation may be dispersed in a suture or
adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver,
pancreas, and
gastrointestinal tract. The formulation may be applied to any site of bleeding, in a
bandage, gauze,
sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the
initial treatment such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized
powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination with an oil and forms a laminate. In another embodiment, the formulation is provided as a
coating on a device, for example a
stent or a
catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent
transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.